Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma
Nicola Gökbuget(Goethe University Frankfurt), D. Hoelzer(Goethe University Frankfurt), F. Huguet(Hôpital Purpan), Reingard Stuhlmann(Asklepios Klinik St. Georg), Lothar Leimer(Robert Bosch Hospital), Hans Guenter Derigs(Klinikum Frankfurt Höchst), Mathias Schmid(Kantonsspital St. Gallen), Jesús María Hernández‐Rivas(Universidad de Salamanca), Albrecht Reichle(University Hospital Regensburg), Christine-Maria Hartog(Goethe University Frankfurt), Tamara Intermesoli(University of Bergamo), R. Greil(Paracelsus Medical University), Josep‐María Ribera(Universitat Autònoma de Barcelona), Hubert Serve(Goethe University Frankfurt), Christian Junghanß(University of Rostock), M. Stelljes(University of Münster), Éric Jourdan(Centre Hospitalier Universitaire de Nîmes), Hervé Dombret(University of London Institute in Paris), M.-J. Moreno(Hospital Clínico Universitario Virgen de la Victoria), Renato Bassan(Pittini Group (Italy))
Cited by 63
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k